Eribulin for recurrent cutaneous angiosarcoma

Br J Dermatol. 2020 Nov;183(5):797-798. doi: 10.1111/bjd.19333. Epub 2020 Jul 27.

Authors

A Smrke¹, C Benson¹

Affiliation

¹ The Royal Marsden Hospital NHS Trust, London, UK.

PMID: 32716049
DOI: 10.1111/bjd.19333

No abstract available

Publication types

Comment

MeSH terms

Furans
Hemangiosarcoma* / drug therapy
Humans
Ketones
Neoplasm Recurrence, Local / drug therapy
Prospective Studies
Taxoids

Substances

Furans
Ketones
Taxoids
eribulin